Cardiovascular Morbidity and Mortality of Cutaneous Psoriasis (PsC) and Psoriatic Arthritis (PsA) are well Documented, with Increased Risks of Myocardial Infarction, Ischemic Heart Disease, and the Metabolic Syndrome in these Patients